反复种植失败的临床处理策略

doi:10.12280/gjszjk.20220171

摘要/Abstract

摘要：

辅助生殖技术的迅速发展使众多不孕不育患者通过体外受精-胚胎移植及其衍生技术成功妊娠,然而仍有部分患者存在多次移植优质胚胎后仍未获得临床妊娠的现象,称为反复种植失败（repeated implantation failure,RIF）。RIF是辅助生殖技术中的难题,同时增加了患者的经济负担,加重患者的身心创伤。如何提高胚胎质量、干预母体自身因素（如改善薄型子宫内膜、提高子宫内膜容受性、抑制子宫收缩、改善高凝状态、免疫抑制治疗）以及改变胚胎移植方法等从而改善妊娠结局是目前临床研究的热点。综述不同病因RIF临床处理策略的研究进展,以期为临床工作者提供参考和治疗思路。

关键词: 不育, 胚胎植入, 胚胎移植, 子宫内膜, 治疗, 妊娠结局

Abstract:

The rapid development of assisted reproductive technology has enabled many infertile patients to get successful pregnances through in vitro fertilization and embryo transfer and its derivative technology. However, there are still some patients who have failed to obtain a clinical pregnancy after transferring high-quality embryos for many times. This is called repeated implantation failure (RIF). RIF is a difficult problem in assisted reproductive technology, which increases the economic burden of patients and aggravates their physical and mental trauma. How to improve embryo quality, to intervene maternal factors (such as improving thin endometrium, improving endometrium receptivity, inhibiting uterine contraction, improving hypercoagulability, immunosuppressive therapy) and to change embryo transfer methods so as to improve pregnancy outcomes, are hot spots in clinical research. The research progress of clinical treatment strategies of RIF due to different etiologies was reviewed in order to provide reference and treatment ideas for clinical workers.

Key words: Infertility, Embryo implantation, Embryo transfer, Endometrium, Therapy, Pregnancy outcome

王焰, 孟庆霞. 反复种植失败的临床处理策略[J]. 国际生殖健康/计划生育, 2022, 41(4): 302-307.

WANG Yan, MENG Qing-xia. Clinical Treatment Strategies of Repeated Implantation Failure[J]. Journal of International Reproductive Health/Family Planning, 2022, 41(4): 302-307.

参考文献 33

[1]	Qiao J, Wang Y, Li X, et al. A Lancet Commission on 70 years of women′s reproductive, maternal, newborn, child, and adolescent health in China[J]. Lancet, 2021, 397(10293):2497-2536. doi: 10.1016/S0140-6736(20)32708-2. doi: 10.1016/S0140-6736(20)32708-2 pmid: 34043953
[2]	Mak JSM, Chung CHS, Chung JPW, et al. The effect of endometrial scratch on natural-cycle cryopreserved embryo transfer outcomes: a randomized controlled study[J]. Reprod Biomed Online, 2017, 35(1):28-36. doi: 10.1016/j.rbmo.2017.04.004. doi: 10.1016/j.rbmo.2017.04.004 URL
[3]	《胚胎植入前遗传学诊断/筛查专家共识》编写组. 胚胎植入前遗传学诊断/筛查技术专家共识[J]. 中华医学遗传学杂志, 2018, 35(2):151-155. doi: 10.3760/cma.j.issn.1003-9406.2018.02.001. doi: 10.3760/cma.j.issn.1003-9406.2018.02.001
[4]	Coughlan C, Ledger W, Wang Q, et al. Recurrent implantation failure: definition and management[J]. Reprod Biomed Online, 2014, 28(1):14-38. doi: 10.1016/j.rbmo.2013.08.011. doi: 10.1016/j.rbmo.2013.08.011 pmid: 24269084
[5]	Cimadomo D, Craciunas L, Vermeulen N, et al. Definition, diagnostic and therapeutic options in recurrent implantation failure: an international survey of clinicians and embryologists[J]. Hum Reprod, 2021, 36(2):305-317. doi: 10.1093/humrep/deaa317. doi: 10.1093/humrep/deaa317 URL
[6]	Tiegs AW, Tao X, Zhan Y, et al. A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing-based preimplantation genetic testing for aneuploidy assay and impact of biopsy[J]. Fertil Steril, 2021, 115(3):627-637. doi: 10.1016/j.fertnstert.2020.07.052. doi: 10.1016/j.fertnstert.2020.07.052 URL
[7]	Tong J, Niu Y, Wan A, et al. Next-Generation Sequencing (NGS)-Based Preimplantation Genetic Testing for Aneuploidy (PGT-A) of Trophectoderm Biopsy for Recurrent Implantation Failure (RIF) Patients:a Retrospective Study[J]. Reprod Sci, 2021, 28(7):1923-1929. doi: 10.1007/s43032-021-00519-0. doi: 10.1007/s43032-021-00519-0 URL
[8]	Wu L, Jin L, Chen W, et al. The true incidence of chromosomal mosaicism after preimplantation genetic testing is much lower than that indicated by trophectoderm biopsy[J]. Hum Reprod, 2021, 36(6):1691-1701. doi: 10.1093/humrep/deab064. doi: 10.1093/humrep/deab064 URL
[9]	Ata B, Kalafat E, Somigliana E. A new definition of recurrent implantation failure on the basis of anticipated blastocyst aneuploidy rates across female age[J]. Fertil Steril, 2021, 116(5):1320-1327. doi: 10.1016/j.fertnstert.2021.06.045. doi: 10.1016/j.fertnstert.2021.06.045 URL
[10]	Liu KE, Hartman M, Hartman A, et al. The impact of a thin endometrial lining on fresh and frozen-thaw IVF outcomes: an analysis of over 40 000 embryo transfers[J]. Hum Reprod, 2018, 33(10):1883-1888. doi: 10.1093/humrep/dey281. doi: 10.1093/humrep/dey281 URL
[11]	Isik G, Oktem M, Guler I, et al. The impact of granulocyte colony-stimulating factor (G-CSF) on thin endometrium of an animal model with rats[J]. Gynecol Endocrinol, 2021, 37(5):438-445. doi: 10.1080/09513590.2020.1786508. doi: 10.1080/09513590.2020.1786508 URL
[12]	Dieamant F, Vagnini LD, Petersen CG, et al. New therapeutic protocol for improvement of endometrial receptivity (PRIMER) for patients with recurrent implantation failure (RIF) - a pilot study[J]. JBRA Assist Reprod, 2019, 23(3):250-254. doi: 10.5935/1518-0557.20190035. doi: 10.5935/1518-0557.20190035 pmid: 31091064
[13]	Enatsu Y, Enatsu N, Kishi K, et al. Clinical outcome of intrauterine infusion of platelet-rich plasma in patients with recurrent implantation failure[J]. Reprod Med Biol, 2022, 21(1):e12417. doi: 10.1002/rmb2.12417. doi: 10.1002/rmb2.12417
[14]	Esmaeilzadeh S, Mohammadi A, Mahdinejad N, et al. Receptivity markers in endometrial mesenchymal stem cells of recurrent implantation failure and non-recurrent implantation failure women: A pilot study[J]. J Obstet Gynaecol Res, 2020, 46(8):1393-1402. doi: 10.1111/jog.14340. doi: 10.1111/jog.14340 URL
[15]	Davar R, Miraj S, Farid Mojtahedi M. Effect of adding human chorionic gonadotropin to frozen thawed embryo transfer cycles with history of thin endometrium[J]. Int J Reprod Biomed, 2016, 14(1):53-56.
[16]	Abdallah KS, Makhlouf A, Badran E, et al. Intrauterine injection of HCG before embryo transfer: a parallel, double-blind randomized trial[J]. Reprod Biomed Online, 2021, 43(4):663-669. doi: 10.1016/j.rbmo.2021.06.011. doi: 10.1016/j.rbmo.2021.06.011 pmid: 34412973
[17]	Aghajanova L, Stavreus-Evers A, Nikas Y, et al. Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium[J]. Fertil Steril, 2003, 79(Suppl 1):808-814. doi: 10.1016/s0015-0282(02)04830-6. doi: 10.1016/s0015-0282(02)04830-6 URL
[18]	Sudoma I, Goncharova Y, Zukin V. Optimization of cryocycles by using pinopode detection in patients with multiple implantation failure: preliminary report[J]. Reprod Biomed Online, 2011, 22(6):590-596. doi: 10.1016/j.rbmo.2011.02.004. doi: 10.1016/j.rbmo.2011.02.004 pmid: 21493157
[19]	Hashimoto T, Koizumi M, Doshida M, et al. Efficacy of the endometrial receptivity array for repeated implantation failure in Japan: A retrospective, two-centers study[J]. Reprod Med Biol, 2017, 16(3):290-296. doi: 10.1002/rmb2.12041. doi: 10.1002/rmb2.12041 pmid: 29259480
[20]	Saxtorph MH, Hallager T, Persson G, et al. Assessing endometrial receptivity after recurrent implantation failure: a prospective controlled cohort study[J]. Reprod Biomed Online, 2020, 41(6):998-1006. doi: 10.1016/j.rbmo.2020.08.015. doi: 10.1016/j.rbmo.2020.08.015 pmid: 32978074
[21]	Lensen S, Osavlyuk D, Armstrong S, et al. A randomized trial of endometrial scratching before in vitro fertilization[J]. N Engl J Med, 2019, 380(4):325-334. doi: 10.1056/NEJMoa1808737. doi: 10.1056/NEJMoa1808737 URL
[22]	Ng EH, Li RH, Chen L, et al. A randomized double blind comparison of atosiban in patients undergoing IVF treatment[J]. Hum Reprod, 2014, 29(12):2687-2694. doi: 10.1093/humrep/deu263. doi: 10.1093/humrep/deu263 URL
[23]	Lan VT, Khang VN, Nhu GH, et al. Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure[J]. Reprod Biomed Online, 2012, 25(3):254-260. doi: 10.1016/j.rbmo.2012.05.014. doi: 10.1016/j.rbmo.2012.05.014 URL
[24]	Mahdian S, Pirjani R, Favaedi R, et al. Platelet-activating factor and antiphospholipid antibodies in recurrent implantation failure[J]. J Reprod Immunol, 2021, 143:103251. doi: 10.1016/j.jri.2020.103251. doi: 10.1016/j.jri.2020.103251 URL
[25]	Han AR, Han JW, Lee SK. Inherited thrombophilia and anticoagulant therapy for women with reproductive failure[J]. Am J Reprod Immunol, 2021, 85(4):e13378. doi: 10.1111/aji.13378. doi: 10.1111/aji.13378
[26]	Lédée N, Petitbarat M, Prat-Ellenberg L, et al. The uterine immune profile: a method for individualizing the management of women who have failed to implant an embryo after IVF/ICSI[J]. J Reprod Immunol, 2020, 142:103207. doi: 10.1016/j.jri.2020.103207. doi: 10.1016/j.jri.2020.103207 URL
[27]	Tohma YA, Musabak U, Gunakan E, et al. The Role of Analysis of NK Cell Subsets in Peripheral Blood and Uterine Lavage Samples in Evaluation of Patients with Recurrent Implantation Failure[J]. J Gynecol Obstet Hum Reprod, 2020, 49(9):101793. doi: 10.1016/j.jogoh.2020.101793. doi: 10.1016/j.jogoh.2020.101793 URL
[28]	Vacca P, Chiossone L, Mingari MC, et al. Heterogeneity of NK cells and other innate lymphoid cells in human and murine decidua[J]. Front Immunol, 2019, 10:170. doi: 10.3389/fimmu.2019.00170. doi: 10.3389/fimmu.2019.00170 URL
[29]	Ghaebi M, Abdolmohammadi-Vahid S, Ahmadi M, et al. T cell Subsets in Peripheral Blood of Women with Recurrent Implantation Failure[J]. J Reprod Immunol, 2019, 131:21-29. doi: 10.1016/j.jri.2018.11.002. doi: 10.1016/j.jri.2018.11.002 URL
[30]	Siristatidis C, Dafopoulos K, El-Khayat W, et al. Administration of prednisolone and low molecular weight heparin in patients with repeated implantation failures: a cohort study[J]. Gynecol Endocrinol, 2018, 34(2):136-139. doi: 10.1080/09513590.2017.1380182. doi: 10.1080/09513590.2017.1380182 pmid: 28949261
[31]	Cheng W, Wu Y, Wu H, et al. Improved pregnancy outcomes of cyclosporine A on patients with unexplained repeated implantation failure in IVF/ICSI cycles: a retrospective cohort study[J]. Am J Reprod Immunol, 2022, 87(4):e13525. doi: 10.1111/aji.13525. doi: 10.1111/aji.13525
[32]	Qu D, Tian X, Ding L, et al. Impacts of Cyclosporin A on clinical pregnancy outcomes of patients with a history of unexplained transfer failure: a retrospective cohort study[J]. Reprod Biol Endocrinol, 2021, 19(1):44. doi: 10.1186/s12958-021-00728-x. doi: 10.1186/s12958-021-00728-x URL
[33]	Stamenov GS, Parvanov DA, Chaushev TA. Mixed double-embryo transfer: A promising approach for patients with repeated implantation failure[J]. Clin Exp Reprod Med, 2017, 44(2):105-110. doi: 10.5653/cerm.2017.44.2.105. doi: 10.5653/cerm.2017.44.2.105 pmid: 28795050